Questionnaire and Laboratory Data on Vitiligo Vulgaris
Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Demographic and Laboratory Data Collection for Patients With Vitiligo Vulgaris|
- Quality of life disturbances in people with vitiligo [ Time Frame: point prevalence ] [ Designated as safety issue: No ]dermatology life quality indices were you used and correlated with location of disease
- self-reporting of vitiligo disease symptoms and history [ Time Frame: single survey ] [ Designated as safety issue: No ]Correlation of the patient survey response with chart documentation was performed.
|Study Start Date:||August 2010|
|Estimated Study Completion Date:||September 2014|
|Estimated Primary Completion Date:||September 2014 (Final data collection date for primary outcome measure)|
Patients who participate in this study will be asked to complete a survey and have blood/ laboratory testing performed that relates or may relate to the diagnosis of vitiligo.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01206374
|United States, New York|
|Department of Dermatology, St. Luke's-Roosevelt Hospital Center|
|New York, New York, United States, 10025|
|Department of Dermatology, Beth Israel Medical Center|
|New York, New York, United States, 10003|
|Principal Investigator:||Nanette Silverberg, MD||StLukesNY|